Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

AlterG

Explore full profile

AlterG | Anti-Gravity Treadmill | Bionic Leg

Hudson, United StatesFounded 2005Health Tech & Medtech
Valuation $50–100M Last recorded · 2012
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for AlterG and the history behind them.

About AlterG

AlterG is a medical device company established in 2005 that provides products for mobility enhancement, physical therapy, and athletic training. The company's origins trace back to founder Sean Whalen and his father, a former NASA research scientist, who developed the initial prototype of the Anti-Gravity Treadmill in their family garage. The concept was born from Sean's graduate studies in entrepreneurship at Stanford University, where he explored the commercial potential of his father's invention, originally designed to help astronauts exercise in space. The underlying technology, known as Differential Air Pressure (DAP), was developed by NASA to allow astronauts to maintain conditioning in space and was later reverse-engineered by AlterG for terrestrial applications. This patented technology creates a pressurized air chamber around the user's lower body, enabling precise unweighting from 100% to as low as 20% of their body weight in 1% increments. The business model centers on the sale of these high-value medical devices to a diverse client base that includes physical therapy clinics, hospitals, skilled nursing facilities, and professional sports teams. Early adoption by organizations like the Nike Oregon Project and various professional sports teams helped validate the technology and establish a market presence. The company's Anti-Gravity Treadmills received FDA clearance as medical devices in 2008, expanding their use into rehabilitation for lower extremity injuries, post-surgery recovery, gait training for neurological conditions, and conditioning for the elderly. AlterG generates revenue through the sale of its treadmill systems, such as the Pro, Via, and Fit models, which are priced for different segments of the rehabilitation and sports performance markets. The company's product line also includes the Bionic Leg, added after the acquisition of Tiburon Corporation. In August 2023, AlterG itself was acquired by ReWalk Robotics (now Lifeward) for approximately $19 million, a move intended to create a more comprehensive portfolio of neurorehabilitation products. AlterG's core product, the Anti-Gravity Treadmill, offers significant benefits by allowing for pain-free movement and the maintenance of normal gait mechanics during recovery and training. This reduces joint impact, limits downtime from injuries, enables earlier post-operative training, and allows athletes to increase training volume with less risk of stress-related injuries. Advanced models incorporate features like Stride Smart, which provides real-time gait analytics, and digital video monitoring to give users and clinicians immediate visual feedback for faster, more effective results. These systems are utilized in over 4,000 facilities globally, including prominent medical centers like Johns Hopkins Medicine and the Mayo Clinic.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2005
Headquarters
Hudson, United States
Employees
36
Open positions
None listed
Dealroom signal
35.4/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Rehabilitation, Neurology, Orthopedic, Wearable, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b
Investment activity
1 company, latest Jun 2013
Capital deployed
—
Preferred round
ACQUISITION

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBT✓Debt Oct 2021 $8M — Cortland Credit Lending Corporation —
Other✓Other financing Sep 2018 $0 — Partner Ventures —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Growth signals

AlterG website traffic

Latest recorded traffic for AlterG is 14K monthly website visits, up 64.7% over the last three months. AlterG's team grew 0% over the past year.

Latest monthly visits14K 3-month web change+64.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later3 investors entered at this stage

Other known investors1 additional known investor

  • Partner Ventures
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about AlterG on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AlterG’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.